Image of The effect of N-acetylcysteine on exacerbations of chronic obstructive pulmonary disease: A meta-analysis and systematic review

LITERATURE

The effect of N-acetylcysteine on exacerbations of chronic obstructive pulmonary disease: A meta-analysis and systematic review


N-acetylcysteine (NAC) is an antioxidant and anti-inflammatory. Its effects on chronic obstructive pulmonary (COPD) outcomes, including exacerbation of and changes in lung function parameters, are controversial. To investigate the effects of NAC on COPD exacerbation and changes in lung function parameters in patients with COPD. A meta-analysis of randomized controlled trials retrieved from
PubMed and Medline databa es (12 trials; 2691 patients). High-dose [relative ratio (RR) ¼ 0.90, 95% confidence interval (CI) ¼ 0.82e0.996, P ¼ 0.041] and low-dose (RR ¼ 0.83, 95% CI ¼ 0.69e0.99, P ¼ 0.043) NAC reduced COPD exacerbation prevalence. Long-term (6 months), but not short-term, NAC reduced exacerbation prevalence (RR ¼ 0.85, 95% CI ¼ 0.74e0.98, P ¼ 0.024). NAC did not affect exacerbation rate, forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), or inspiratory capacity
(IC). Long-term NAC therapy may reduce risk of COPD exacerbation


Availability

REQJ4698Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Heart & Lung xxx (2017) 1e9
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous